|
05 Aug 2021 |
Rgenta Therapeutics Enters into a Collaboration with Lundbeck
|
|
05 Aug 2021 |
Bayer strengthens drug discovery platform through acquisition of Vividion Therapeutics
|
|
04 Aug 2021 |
Excel Diagnostics and Nuclear Oncology Center Announces FDA Authorization of IND for 225Ac-PSMA I&T Targeted Alpha Therapy for Castration Resistant Prostate Cancer
|
|
03 Aug 2021 |
Sanofi to Acquire Translate Bio; Advances Deployment of mRNA Technology across Vaccines and Therapeutics Development
|
|
02 Aug 2021 |
Autolus and Moderna sign Option and License Agreement for access to proprietary targeting technology from Autolus
|
|
02 Aug 2021 |
Ipsen and Exicure Enter Into Exclusive Collaboration Targeting Rare Neurodegenerative Disorders
|
|
31 Jul 2021 |
Astellas and Minovia Therapeutics Announce Strategic Collaboration for Novel Mitochondrial Cell Therapy Programs
|
|
30 Jul 2021 |
Alnylam and PeptiDream Enter into Collaboration Agreement to Discover and Develop Peptide-siRNA Conjugates for Targeted Delivery of RNAi Therapeutics to a Broader Range of Extrahepatic Tissues
|
|
29 Jul 2021 |
Lilly and Kumquat Biosciences Announce Collaboration to Discover and Develop Novel Small Molecules that Stimulate Tumor-Specific Immune Responses
|
|
28 Jul 2021 |
PeptiDream and Takeda Expand Collaborative Research and License Agreement to Develop Peptide Drug Conjugates for CNS Diseases
|
|
28 Jul 2021 |
Ipsen Strengthens Its Pre-clinical Oncology Pipeline With an Exclusive Worldwide-collaboration With BAKX Therapeutics Inc. for BKX-001, Targeting the Apoptosis Pathway
|
|
28 Jul 2021 |
Arena Pharmaceuticals and Aristea Therapeutics Establish Collaboration for Development of RIST4721 for Treatment of Serious Immune-Mediated Inflammatory Diseases
|
|
28 Jul 2021 |
AC Immune Announces Strategic Acquisition of Industry-leading Parkinson’s Disease Vaccine Candidate and Equity Investment Led by Athos Service GmbH
|
|
28 Jul 2021 |
AstraZeneca and Regeneron to research, develop and commercialise new small molecule medicines for obesity
|
|
27 Jul 2021 |
Organon and ObsEva Enter Global License Agreement to Develop and Commercialize Ebopiprant (OBE022), an Investigational Agent Being Evaluated as a First-in-Class Treatment for Preterm Labor
|
|
22 Jul 2021 |
Mirimus, Inc. Forms Strategic Collaboration with Biogen to Develop RNAi-Based Therapeutics for Neurological Disease Indications
|
|
21 Jul 2021 |
NanoSyrinx raises £6.2m to develop its synthetic biology platform for targeted intracellular engineering
|
|
20 Jul 2021 |
Junshi Biosciences and Immorna Announce Joint Venture to Develop Innovative Self-Replicating and Conventional mRNA Therapeutics and Vaccines
|
|
17 Jul 2021 |
GC LabCell and GC Cell to Merge, Creating a Premier Cell Therapy Company
|
|
16 Jul 2021 |
Ipsen and IRLAB Enter Exclusive Worldwide Licensing Agreement Aimed to Improve the Lives of People Living with Parkinson’s Disease
|
|
15 Jul 2021 |
Lilly Announces Acquisition of Protomer Technologies
|
|
13 Jul 2021 |
ExCellThera and Astellas enter into a license for the use of molecule UM171 in the field of pluripotent stem cells
|
|
13 Jul 2021 |
eTheRNA immunotherapies and Ghent University Announce mRNA Delivery Collaboration and License Agreement
|
|
13 Jul 2021 |
48Hour Discovery and RayzeBio Announce Strategic Research Collaboration to Discover & Develop Novel Peptide-Based Radiopharmaceuticals
|
|
13 Jul 2021 |
Ionis enters exclusive licensing agreement with Bicycle Therapeutics aimed at further advancing LICA technology
|
